MoonLake Immunotherapeutics Reports Third Quarter 2025 Financial Results and Announces New Data from Clinical Trials of its Nanobody® Sonelokimab

Ended the third quarter with $380.5 million in cash, cash equivalents and short-term marketable debt securities which, together with funds from a ...

MoonLake Immunotherapeutics AG: MoonLake Immunotherapeutics Reports Third Quarter 2025 Financial Results and Announces New Data from Clinical Trials of its Nanobody Sonelokimab

Ended the third quarter with $380.5 million in cash, cash equivalents and short-term marketable debt securities which, together with funds from a previously announced debt-facility, are expected to pr ...

Centennial Spine and Pain offers treatments for chronic joint pain

Centennial Spine and Pain offers best-in-class, minimally invasive treatments for individuals experiencing all types of pain.
Scientific American

COVID Is Beginning to Surge Globally. Here’s What We Know

First published in 1869, Nature is the world's leading multidisciplinary science journal. Nature publishes the finest ...
Everyday Health on MSN

Signs of Chronic Inflammation: Common and Surprising Symptoms

Chronic inflammation may be subtle but can indicate serious health issues. Discover common and surprising symptoms, and learn ...